Kathleen M. Hunter-Gregory
Treasurer bei Sertoli Technologies LLC
Aktive Positionen von Kathleen M. Hunter-Gregory
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sertoli Technologies LLC
 Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Treasurer | 15.02.2010 | - |
Karriereverlauf von Kathleen M. Hunter-Gregory
Ehemalige bekannte Positionen von Kathleen M. Hunter-Gregory
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Comptroller/Controller/Auditor | 01.01.1992 | - |
Ausbildung von Kathleen M. Hunter-Gregory
| University of Arizona | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Treasurer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Sertoli Technologies LLC
Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Health Services |
